Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trialYuankai Shi, Peng Liu, Yuhuan Gao et al.|The Lancet Haematology|2019Cited by 248
Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in miceShan Zeng, Jean C. Emond|Hepatology|2004Cited by 177
ZEB1 Promotes Oxaliplatin Resistance through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer CellsCao Guo, Shan Zeng|Journal of Cancer|2017Cited by 58
<p>FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer</p>Yihong Chen, Shan Zeng|OncoTargets and Therapy|2020Cited by 45
Activation of VIPR1 suppresses hepatocellular carcinoma progression by regulating arginine and pyrimidine metabolismYaojie Fu, Hong Shen, Shanshan Liu et al.|International Journal of Biological Sciences|2022Cited by 32